Search research articles
Contact Us
Filters
Showing results (71-80 of 217) with videos related to
Page
of 22
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 7, 2006
HES1 cooperates with pRb to activate RUNX2-dependent transcription
Jong-Seo Lee, David M Thomas, Gabriel Gutierrez, et al.
Brain Research
|
April 4, 2006
Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies
Stacey A Sakowski, Timothy J Geddes, David M Thomas, et al.
JAMA Oncology
|
August 4, 2017
Surveillance in Germline TP53 Mutation Carriers Utilizing Whole-Body Magnetic Resonance Imaging
Mandy L Ballinger, Nicholas J Ferris, Kate Moodie, et al.
JCO Precision Oncology
|
December 1, 2022
Clinical Response to Seribantumab, an Anti-Human Epidermal Growth Factor Receptor-3 Immunoglobulin 2 Monoclonal Antibody, in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma Harboring an <i>NRG1</i> Fusion
Subotheni Thavaneswaran, Wei Yen Chan, Ray Asghari, et al.
Cancer Cell
|
June 11, 2024
Testing dilemmas in the clinic: Lessons learned from biomarker-based drug development
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Olga Kholmanskikh Van Criekingen, Simone Koole, et al.
Nature Reviews. Clinical Oncology
|
April 19, 2019
Author Correction: Therapeutic implications of germline genetic findings in cancer
Subotheni Thavaneswaran, Emma Rath, Kathy Tucker, et al.
Journal of Genetic Counseling
|
February 19, 2018
Development and Pilot Testing of a Decision Aid for Genomic Research Participants Notified of Clinically Actionable Research Findings for Cancer Risk
Amanda M Willis, Sian K Smith, Bettina Meiser, et al.
Nature Reviews. Clinical Oncology
|
February 21, 2019
Therapeutic implications of germline genetic findings in cancer
Subotheni Thavaneswaran, Emma Rath, Kathy Tucker, et al.
Surgery
|
October 18, 2024
Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) program
Elan Novis, Anthony Glover, John P Grady, et al.
Biochemical and Biophysical Research Communications
|
July 25, 2003
A role for alphaV integrin subunit in TGF-beta-stimulated osteoclastogenesis
Synn Lynn Chin, Sandra A Johnson, Julian Quinn, et al.
Page
of 22
Search research articles
Search
Showing results (71-80 of 217) with videos related to
Sort By:
Page
of 22
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 7, 2006
HES1 cooperates with pRb to activate RUNX2-dependent transcription
Jong-Seo Lee, David M Thomas, Gabriel Gutierrez, et al.
Brain Research
|
April 4, 2006
Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies
Stacey A Sakowski, Timothy J Geddes, David M Thomas, et al.
JAMA Oncology
|
August 4, 2017
Surveillance in Germline TP53 Mutation Carriers Utilizing Whole-Body Magnetic Resonance Imaging
Mandy L Ballinger, Nicholas J Ferris, Kate Moodie, et al.
JCO Precision Oncology
|
December 1, 2022
Clinical Response to Seribantumab, an Anti-Human Epidermal Growth Factor Receptor-3 Immunoglobulin 2 Monoclonal Antibody, in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma Harboring an <i>NRG1</i> Fusion
Subotheni Thavaneswaran, Wei Yen Chan, Ray Asghari, et al.
Cancer Cell
|
June 11, 2024
Testing dilemmas in the clinic: Lessons learned from biomarker-based drug development
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Olga Kholmanskikh Van Criekingen, Simone Koole, et al.
Nature Reviews. Clinical Oncology
|
April 19, 2019
Author Correction: Therapeutic implications of germline genetic findings in cancer
Subotheni Thavaneswaran, Emma Rath, Kathy Tucker, et al.
Journal of Genetic Counseling
|
February 19, 2018
Development and Pilot Testing of a Decision Aid for Genomic Research Participants Notified of Clinically Actionable Research Findings for Cancer Risk
Amanda M Willis, Sian K Smith, Bettina Meiser, et al.
Nature Reviews. Clinical Oncology
|
February 21, 2019
Therapeutic implications of germline genetic findings in cancer
Subotheni Thavaneswaran, Emma Rath, Kathy Tucker, et al.
Surgery
|
October 18, 2024
Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) program
Elan Novis, Anthony Glover, John P Grady, et al.
Biochemical and Biophysical Research Communications
|
July 25, 2003
A role for alphaV integrin subunit in TGF-beta-stimulated osteoclastogenesis
Synn Lynn Chin, Sandra A Johnson, Julian Quinn, et al.
Page
of 22